China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Clinical Study of Dose Escalation in Definitive Radiotherapy for Esophageal Cancer Based on Online Adaptive Radiotherapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130505
Registration Time: 2026/08/20
Type: Interventional study
Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338669
Published by HT Digital Content Services with permission from Health Daily Digest....